Literature DB >> 23283973

Mouse prion protein polymorphism Phe-108/Val-189 affects the kinetics of fibril formation and the response to seeding: evidence for a two-step nucleation polymerization mechanism.

Leonardo M Cortez1, Jitendra Kumar, Ludovic Renault, Howard S Young, Valerie L Sim.   

Abstract

Prion diseases are fatal neurodegenerative disorders associated with the polymerization of the cellular form of prion protein (PrP(C)) into an amyloidogenic β-sheet infectious form (PrP(Sc)). The sequence of host PrP is the major determinant of host prion disease susceptibility. In mice, the presence of allele a (Prnp(a), encoding the polymorphism Leu-108/Thr-189) or b (Prnp(b), Phe-108/Val-189) is associated with short or long incubation times, respectively, following infection with PrP(Sc). The molecular bases linking PrP sequence, infection susceptibility, and convertibility of PrP(C) into PrP(Sc) remain unclear. Here we show that recombinant PrP(a) and PrP(b) aggregate and respond to seeding differently in vitro. Our kinetic studies reveal differences during the nucleation phase of the aggregation process, where PrP(b) exhibits a longer lag phase that cannot be completely eliminated by seeding the reaction with preformed fibrils. Additionally, PrP(b) is more prone to propagate features of the seeds, as demonstrated by conformational stability and electron microscopy studies of the formed fibrils. We propose a model of polymerization to explain how the polymorphisms at positions 108 and 189 produce the phenotypes seen in vivo. This model also provides insight into phenomena such as species barrier and prion strain generation, two phenomena also influenced by the primary structure of PrP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23283973      PMCID: PMC3576082          DOI: 10.1074/jbc.M112.414581

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  Prion strains and species barriers.

Authors:  Andrew F Hill; John Collinge
Journal:  Contrib Microbiol       Date:  2004

2.  Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation.

Authors:  H Fraser; A G Dickinson
Journal:  J Comp Pathol       Date:  1973-01       Impact factor: 1.311

3.  Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathway.

Authors:  M F Bishop; F A Ferrone
Journal:  Biophys J       Date:  1984-11       Impact factor: 4.033

4.  Probing the instabilities in the dynamics of helical fragments from mouse PrPC.

Authors:  Ruxandra I Dima; D Thirumalai
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-19       Impact factor: 11.205

5.  Experimental subacute spongiform virus encephalopathies in primates and other laboratory animals.

Authors:  C J Gibbs; D C Gajdusek
Journal:  Science       Date:  1973-10-05       Impact factor: 47.728

6.  The fate of ME7 scrapie infection in rats, guinea-pigs and rabbits.

Authors:  R M Barlow; J C Rennie
Journal:  Res Vet Sci       Date:  1976-07       Impact factor: 2.534

7.  Identification and characterization of a novel mouse prion gene allele.

Authors:  Sarah E Lloyd; Simon R Thompson; Jonathan A Beck; Jacqueline M Linehan; Jonathan D F Wadsworth; Sebastian Brandner; John Collinge; Elizabeth M C Fisher
Journal:  Mamm Genome       Date:  2004-05       Impact factor: 2.957

8.  Distinct prion proteins in short and long scrapie incubation period mice.

Authors:  D Westaway; P A Goodman; C A Mirenda; M P McKinley; G A Carlson; S B Prusiner
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

9.  Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism.

Authors:  F A Ferrone; J Hofrichter; W A Eaton
Journal:  J Mol Biol       Date:  1985-06-25       Impact factor: 5.469

10.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

View more
  7 in total

1.  Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.

Authors:  Leonardo M Cortez; Jody Campeau; Grant Norman; Marian Kalayil; Jacques Van der Merwe; Debbie McKenzie; Valerie L Sim
Journal:  J Virol       Date:  2015-08       Impact factor: 5.103

Review 2.  Implications of prion polymorphisms.

Authors:  Leonardo M Cortez; Valerie L Sim
Journal:  Prion       Date:  2013-06-27       Impact factor: 3.931

3.  The role of the unusual threonine string in the conversion of prion protein.

Authors:  Romany Abskharon; Fei Wang; Kayla J Vander Stel; Kumar Sinniah; Jiyan Ma
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

4.  Pharmacological chaperone reshapes the energy landscape for folding and aggregation of the prion protein.

Authors:  Amar Nath Gupta; Krishna Neupane; Negar Rezajooei; Leonardo M Cortez; Valerie L Sim; Michael T Woodside
Journal:  Nat Commun       Date:  2016-06-27       Impact factor: 14.919

Review 5.  Recombinant PrP and Its Contribution to Research on Transmissible Spongiform Encephalopathies.

Authors:  Jorge M Charco; Hasier Eraña; Vanessa Venegas; Sandra García-Martínez; Rafael López-Moreno; Ezequiel González-Miranda; Miguel Ángel Pérez-Castro; Joaquín Castilla
Journal:  Pathogens       Date:  2017-12-14

6.  Generation of a new infectious recombinant prion: a model to understand Gerstmann-Sträussler-Scheinker syndrome.

Authors:  Saioa R Elezgarai; Natalia Fernández-Borges; Hasier Eraña; Alejandro M Sevillano; Jorge M Charco; Chafik Harrathi; Paula Saá; David Gil; Qingzhong Kong; Jesús R Requena; Olivier Andréoletti; Joaquín Castilla
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

7.  Quaternary Structure Changes for PrPSc Predate PrPC Downregulation and Neuronal Death During Progression of Experimental Scrapie Disease.

Authors:  Ghazaleh Eskandari-Sedighi; Leonardo M Cortez; Jing Yang; Nathalie Daude; Klinton Shmeit; Valerie Sim; David Westaway
Journal:  Mol Neurobiol       Date:  2020-09-21       Impact factor: 5.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.